POLARIS THERAPEUTICS
LIVE

Serial Number

97744470

Owner

Polaris Therapeutics, Inc.

Attorney

Julia Spoor Gard

Filing Date

Jan 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

POLARIS THERAPEUTICS Trademark

Serial Number: 97744470

POLARIS THERAPEUTICS is a trademark filed by Polaris Therapeutics, Inc. on January 6, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Polaris Therapeutics, Inc.

201 Haskins Way, 5th Floor
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

January 6, 2023

Registration Date

Not Registered

Goods & Services

pharmaceutical research and development in the field of rare diseases; pharmaceutical products development, namely, development of pharmaceutical products for the treatment and prevention of rare diseases

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 22, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 21, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 18, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 17, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 15, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 21, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 21, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 21, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 10, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 10, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2023 NWOS
NEW APPLICATION ENTERED
Jan 10, 2023 NWAP